These outcomes, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 assist the notion of focusing on ACKR3 as a unique solution to modulate the opioid procedure, which could open new therapeutic avenues for opioid-relevant Diseases. Study on conolidine is proscribed, https://camillat514djp2.blogoxo.com/profile